Table 8:
Scenario Analysis—Expected Costs, QALYs, and ICERs With MRgHIFU-Eligible Population Only
| Treatment Strategy | Total | Incremental | ICER | ||
|---|---|---|---|---|---|
| Costs | QALYs | Costs | QALYs | $/QALY | |
| Hysterectomy | $8,485.48 | 6.221 | Reference | Reference | Reference |
| Myomectomy | $13,399.09 | 6.229 | $4,913.52 | 0.008 | Dominateda |
| MRgHIFU | $10,123.27 | 6.271 | $1,637,79 | 0.050 | $32,756.86 |
| UAE | $11,106.62 | 6.285 | $2,621.14 | 0.064 | $70,239.29b |
Abbreviations: ICER, incremental cost-effectiveness ratio; MRgHIFU, magnetic resonance-guided high-intensity focused ultrasound; QALY, quality-adjusted life-year; UAE, uterine artery embolization.
a
Myomectomy is strictly dominated by MRgHIFU and UAE.
b
ICER value of UAE as compared with MRgHIFU.